SIGA Technologies
E521269
SIGA Technologies is a pharmaceutical company specializing in the development of antiviral treatments, particularly for smallpox and other orthopoxvirus infections.
Statements (46)
| Predicate | Object |
|---|---|
| instanceOf |
pharmaceutical company
ⓘ
public company ⓘ |
| countryOfIncorporation | United States NERFINISHED ⓘ |
| develops |
ST-246
NERFINISHED
ⓘ
TPOXX NERFINISHED ⓘ tecovirimat NERFINISHED ⓘ |
| drugTargetPathogen |
monkeypox virus
NERFINISHED
ⓘ
orthopoxviruses ⓘ variola virus ⓘ |
| focusesOn |
biodefense
ⓘ
health security ⓘ |
| foundedIn | 1995 ⓘ |
| hasBrandName | TPOXX NERFINISHED ⓘ |
| hasBusinessModel | development of medical countermeasures for biodefense ⓘ |
| hasCollaboration | U.S. Biomedical Advanced Research and Development Authority NERFINISHED ⓘ |
| hasContractWith |
U.S. Biomedical Advanced Research and Development Authority
NERFINISHED
ⓘ
U.S. Department of Health and Human Services NERFINISHED ⓘ |
| hasOrphanDrugDesignation | tecovirimat NERFINISHED ⓘ |
| hasRegulatoryApproval |
European Medicines Agency
NERFINISHED
ⓘ
Health Canada NERFINISHED ⓘ U.S. Food and Drug Administration NERFINISHED ⓘ United Kingdom Medicines and Healthcare products Regulatory Agency NERFINISHED ⓘ |
| headquartersCountry |
United States of America
ⓘ
surface form:
United States
|
| headquartersLocation | New York City ⓘ |
| headquartersState | New York NERFINISHED ⓘ |
| industry |
biotechnology
ⓘ
pharmaceuticals ⓘ |
| listedOn | NASDAQ ⓘ |
| notableProduct |
ST-246
NERFINISHED
ⓘ
TPOXX NERFINISHED ⓘ tecovirimat NERFINISHED ⓘ |
| primaryTherapeuticArea |
infectious diseases
ⓘ
viral infections ⓘ |
| productIndication |
monkeypox
ⓘ
orthopoxvirus infections ⓘ smallpox ⓘ |
| researchFocus |
orthopoxvirus countermeasures
ⓘ
small-molecule antivirals ⓘ |
| servesCustomer |
government agencies
ⓘ
public health authorities ⓘ |
| specializesIn |
antiviral treatments
ⓘ
orthopoxvirus infections ⓘ smallpox therapeutics ⓘ |
| supplies | U.S. Strategic National Stockpile NERFINISHED ⓘ |
| therapeuticModality | oral antiviral drugs ⓘ |
| tradedAs | NASDAQ:SIGA NERFINISHED ⓘ |
Referenced by (1)
Full triples — surface form annotated when it differs from this entity's canonical label.